Roche RHHBY announced that the FDA has accepted and granted priority review to its supplemental biologics license application (sBLA) seeking label expansion of Enspryng (satralizumab) for the

The Cooper Companies COO has enough operating strength to keep investors interested, but not enough near-term clarity to make the setup simple.

Premium contact lenses, myopia control and fertility

The Cooper Companies, Inc. COO has two durable healthcare platforms, but its investment case is being shaped by execution as much as demand.

Premium contact lenses, myopia control and fertility

GE Aerospace GE and Textron Inc. TXT are two prominent names operating in the aerospace and defense industry. As rivals, both companies are engaged in producing highly engineered aircraft components

Honeywell Technologies HON recently emerged as a separate public company, following the spin-off of Aerospace Technologies business from Honeywell International. The Aerospace Technologies business

Everpure, Inc. P ended the first quarter of fiscal 2027 with a cash balance of $1.5 billion, providing an ample cushion against its debt position. Everpure’s balance sheet shows a massive net-cash

Argan, Inc. AGX continues to capitalize on the robust U.S. energy infrastructure buildout, but like most engineering, procurement and construction (EPC) contractors, it remains exposed to execution

MP Materials’ MP first-quarter 2026 results underscore the success of its efforts to expand neodymium-praseodymium (NdPr) production, with the Materials business delivering strong operational